Supplemental material
OncoImmunology
Volume 8, 2019 - Issue 3
Original Research
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches
Elise RamiaDepartment of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy
https://orcid.org/0000-0002-5695-7499View further author information
https://orcid.org/0000-0002-5695-7499View further author information, Anna Maria ChiaravalliDepartment of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italyhttps://orcid.org/0000-0002-3924-2117View further author information
https://orcid.org/0000-0002-3924-2117View further author information, Farah Bou Nasser EddineDepartment of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italyhttps://orcid.org/0000-0001-9593-9085View further author information
https://orcid.org/0000-0001-9593-9085View further author information, , , Roberto S. AccollaDepartment of Medicine and Surgery, School of Medicine, University of Insubria, Varese, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-2493-7378View further author information
https://orcid.org/0000-0003-2493-7378View further author information & Greta ForlaniDepartment of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italyhttps://orcid.org/0000-0003-1987-7761View further author information
https://orcid.org/0000-0003-1987-7761View further author information show allReprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine.
Source:
Frontiers Media SA
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker
Source:
Decker Periodicals Publ Inc
Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
Source:
Elsevier BV
MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes
Source:
Wiley
Regulation of PD-L1: a novel role of pro-survival signalling in cancer
Source:
Elsevier BV
HLA expression in human hepatocellular carcinoma.
Source:
Springer Science and Business Media LLC
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
Source:
Springer Science and Business Media LLC
MethPrimer: designing primers for methylation PCRs
Source:
Oxford University Press (OUP)
Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma.
Source:
American Society for Clinical Investigation
The MHC class II transactivator: prey and hunter in infectious diseases
Source:
Elsevier BV
Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
Source:
American Association for the Advancement of Science (AAAS)
HEPATOBILIARY MALIGNANCIES
Source:
Wiley
Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes.
Source:
Rockefeller University Press
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.
Source:
American Association for Cancer Research (AACR)
HEPATOLOGY, Vol. 00, No. X, 2014
Source:
Wiley
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL
Source:
Springer Science and Business Media LLC
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Source:
Rockefeller University Press
aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.
Source:
Rockefeller University Press
Activation of the MHC Class II Transactivator CIITA by Interferon-γ Requires Cooperative Interaction between Stat1 and USF-1
Source:
Elsevier BV
Linking provided by
